DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Pipe S, Stine K, Rajasekhar A. , et al.
101HEMB01, a phase 1/2 open-label single ascending dose-finding trial of DTX101 (AAVrh10FIX) in patients with moderate/severe to severe hemophilia B demonstrated meaningful but transient expression of human factor IX.
Blood 2017;
130: 3333
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.